Clinical Trial Update: Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating Entinostat in combination with ZEN003694 for advanced solid tumors, including locally advanced and metastatic pancreatic can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Unresectable Pancreatic Cancer

Drugs mentioned

• Entinostat (entinostat)
• ZEN003694

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Solid Neoplasm, Locally Advanced Pancreatic Carcinoma | Phase 1, Phase 2 | Status: RECRUITING